Research ExplorerPublications[Venous thrombembolism in tumour patients].

[Venous thrombembolism in tumour patients].

Standard

[Venous thrombembolism in tumour patients]. / Pabinger, I; Alt-Epping, B; Demarmels Biasutti, F; Langer, Florian; Wörmann, B; Riess, H.

In: HAMOSTASEOLOGIE, Vol. 31, No. 4, 4, 2011, p. 281-282.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Pabinger, I, Alt-Epping, B, Demarmels Biasutti, F, Langer, F, Wörmann, B & Riess, H 2011, '[Venous thrombembolism in tumour patients].', HAMOSTASEOLOGIE, vol. 31, no. 4, 4, pp. 281-282. <http://www.ncbi.nlm.nih.gov/pubmed/21983992?dopt=Citation>

APA

Pabinger, I., Alt-Epping, B., Demarmels Biasutti, F., Langer, F., Wörmann, B., & Riess, H. (2011). [Venous thrombembolism in tumour patients]. HAMOSTASEOLOGIE, 31(4), 281-282. [4]. http://www.ncbi.nlm.nih.gov/pubmed/21983992?dopt=Citation

Vancouver

Pabinger I, Alt-Epping B, Demarmels Biasutti F, Langer F, Wörmann B, Riess H. [Venous thrombembolism in tumour patients]. HAMOSTASEOLOGIE. 2011;31(4):281-282. 4.

Bibtex

@article{85ae4ebb660b45b69055896d728edd2c,
title = "[Venous thrombembolism in tumour patients].",
abstract = "Venous thrombembolism (VTE) is one of the most frequent complication in cancer patients. The current options in prophylaxis and therapy have to be balanced against the risks of major bleeding and the burden for the patients. The Gesellschaft f{\"u}r Thrombose- und H{\"a}mostaseforschung, the Deutsche Gesellschaft f{\"u}r Palliativmedizin and the German speaking Societies of Hematology and Oncology have recently published guidelines on VTE in cancer patients. Recommendations include diagnostics, individual prophylaxis and treatment.",
keywords = "Humans, Anticoagulants/administration & dosage/*adverse effects, Hemorrhage/*chemically induced/*prevention & control, Neoplasms/*complications/*therapy, Venous Thromboembolism/*etiology/*therapy, Humans, Anticoagulants/administration & dosage/*adverse effects, Hemorrhage/*chemically induced/*prevention & control, Neoplasms/*complications/*therapy, Venous Thromboembolism/*etiology/*therapy",
author = "I Pabinger and B Alt-Epping and {Demarmels Biasutti}, F and Florian Langer and B W{\"o}rmann and H Riess",
year = "2011",
language = "Deutsch",
volume = "31",
pages = "281--282",
journal = "HAMOSTASEOLOGIE",
issn = "0720-9355",
publisher = "Schattauer",
number = "4",

}

RIS

TY - JOUR

T1 - [Venous thrombembolism in tumour patients].

AU - Pabinger, I

AU - Alt-Epping, B

AU - Demarmels Biasutti, F

AU - Langer, Florian

AU - Wörmann, B

AU - Riess, H

PY - 2011

Y1 - 2011

N2 - Venous thrombembolism (VTE) is one of the most frequent complication in cancer patients. The current options in prophylaxis and therapy have to be balanced against the risks of major bleeding and the burden for the patients. The Gesellschaft für Thrombose- und Hämostaseforschung, the Deutsche Gesellschaft für Palliativmedizin and the German speaking Societies of Hematology and Oncology have recently published guidelines on VTE in cancer patients. Recommendations include diagnostics, individual prophylaxis and treatment.

AB - Venous thrombembolism (VTE) is one of the most frequent complication in cancer patients. The current options in prophylaxis and therapy have to be balanced against the risks of major bleeding and the burden for the patients. The Gesellschaft für Thrombose- und Hämostaseforschung, the Deutsche Gesellschaft für Palliativmedizin and the German speaking Societies of Hematology and Oncology have recently published guidelines on VTE in cancer patients. Recommendations include diagnostics, individual prophylaxis and treatment.

KW - Humans

KW - Anticoagulants/administration & dosage/adverse effects

KW - Hemorrhage/chemically induced/prevention & control

KW - Neoplasms/complications/therapy

KW - Venous Thromboembolism/etiology/therapy

KW - Humans

KW - Anticoagulants/administration & dosage/adverse effects

KW - Hemorrhage/chemically induced/prevention & control

KW - Neoplasms/complications/therapy

KW - Venous Thromboembolism/etiology/therapy

M3 - SCORING: Zeitschriftenaufsatz

VL - 31

SP - 281

EP - 282

JO - HAMOSTASEOLOGIE

JF - HAMOSTASEOLOGIE

SN - 0720-9355

IS - 4

M1 - 4

ER -